top
Search terms
Results 1 - 5 of 5 - ordered by :
Escardio

Up to 50% of patients with ST-segment elevation myocardial infarction (STEMI) have multivessel coronary artery disease. Prior randomised trials found declines in composite outcomes with non-culprit ...

Date : 01/09/2019
Escardio

The antithrombin drug rivaroxaban does not reduce the risk of a composite endpoint of survival, myocardial infarction and stroke after an episode of worsening heart failure in patients with heart ...

Date : 27/08/2018
Escardio

Having a non-O blood group is associated with a higher risk of heart attack, according to research presented today at Heart Failure 2017 and the 4th World Congress on Acute Heart Failure.1 Lead ...

Date : 30/04/2017
Escardio

EMBARGO : 30 August 2015 at 14:15 BST “Acute coronary syndromes, including myocardial infarction (heart attack) and unstable angina (threatened heart attack), are a leading cause of death and ...

Date : 30/08/2015
Escardio

[...]many users are also prescribed a proton pump inhibitor (PPI). [...]a meta-analysis of almost 160,000 patients carried out at the Medical University of Vienna and Wilhelminenhospital, Vienna, ...

Date : 20/08/2010